Vertebrates have two Armadillo-like proteins, beta -catenin and plakoglobin
. Mutant forms of beta -catenin with oncogenic activity are found in many h
uman tumors, but plakoglobin mutations are not commonly found, In fact, pla
koglobin has been proposed to suppress tumorigenesis, To assess differences
between beta -catenin and plakoglobin, we compared several of their bioche
mical properties, After transient transfection of 293T cells with an expres
sion vector encoding either of the two proteins, soluble wild type beta -ca
tenin does not significantly accumulate, whereas soluble wild type plakoglo
bin is readily detected. As anticipated, beta -catenin is stabilized by the
oncogenic mutation S37A; however, the analogous mutation in plakoglobin (S
28A) does not alter its half-life. S37A-beta -catenin activates a TCF/LEF-d
ependent reporter 20-fold more potently than wild type beta -catenin, and s
imilar to5-fold more potently than wild type or S28A plakoglobin. These dif
ferences may be attributable to an enhanced affinity of S37A beta -catenin
for LEF1 and TCF4, as observed here by immunoprecipitation assays. We show
that the carboxyl-terminal domain is largely responsible for the difference
in signaling and that the Armadillo repeats account for the remainder of t
he difference, The relatively weak signaling by plakoglobin and the failure
of the S28A mutation to enhance its stability, may explain why plakoglobin
mutations are infrequent in malignancies.